A. Aßmann

556 total citations
22 papers, 395 citations indexed

About

A. Aßmann is a scholar working on Public Health, Environmental and Occupational Health, Internal Medicine and Hematology. According to data from OpenAlex, A. Aßmann has authored 22 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 8 papers in Internal Medicine and 7 papers in Hematology. Recurrent topics in A. Aßmann's work include Reproductive Health and Contraception (8 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). A. Aßmann is often cited by papers focused on Reproductive Health and Contraception (8 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). A. Aßmann collaborates with scholars based in Germany, Canada and Austria. A. Aßmann's co-authors include Lothar Heinemann, Thai DoMinh, Jürgen Dinger, Edeltraut Garbe, Thai Do Minh, Sabine Möhner, Michael A. O. Lewis, Christine Thiel, Michael Spannagl and I. Guggenmoos-Holzmann and has published in prestigious journals such as BMC Medical Research Methodology, BMC Cancer and Contraception.

In The Last Decade

A. Aßmann

20 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Aßmann Germany 13 234 111 94 93 61 22 395
J.‐C. Todd United Kingdom 5 151 0.6× 103 0.9× 133 1.4× 57 0.6× 110 1.8× 6 362
Annica Bergendal Sweden 13 99 0.4× 105 0.9× 99 1.1× 50 0.5× 87 1.4× 16 415
Kresten Rubeck Petersen Denmark 13 176 0.8× 77 0.7× 36 0.4× 51 0.5× 23 0.4× 21 391
Frederick Pellegrin United States 8 151 0.6× 37 0.3× 35 0.4× 52 0.6× 35 0.6× 8 291
Sabine Möhner Germany 10 188 0.8× 24 0.2× 21 0.2× 81 0.9× 22 0.4× 12 274
G Rybo Sweden 11 179 0.8× 46 0.4× 10 0.1× 38 0.4× 25 0.4× 25 506
Reinhard Meister Germany 6 127 0.5× 64 0.6× 51 0.5× 72 0.8× 117 1.9× 9 315
J Tzafettas Greece 11 89 0.4× 64 0.6× 9 0.1× 103 1.1× 25 0.4× 35 326
Torun Clausen Norway 13 98 0.4× 51 0.5× 8 0.1× 681 7.3× 45 0.7× 15 924
Osman Şevket Türkiye 14 161 0.7× 11 0.1× 8 0.1× 117 1.3× 48 0.8× 39 496

Countries citing papers authored by A. Aßmann

Since Specialization
Citations

This map shows the geographic impact of A. Aßmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Aßmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Aßmann more than expected).

Fields of papers citing papers by A. Aßmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Aßmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Aßmann. The network helps show where A. Aßmann may publish in the future.

Co-authorship network of co-authors of A. Aßmann

This figure shows the co-authorship network connecting the top 25 collaborators of A. Aßmann. A scholar is included among the top collaborators of A. Aßmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Aßmann. A. Aßmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heinemann, Lothar, Jürgen Dinger, A. Aßmann, & Thai Do Minh. (2010). Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10 years after the third-generation “pill scare”. Contraception. 81(5). 401–407. 32 indexed citations
2.
Dinger, Jürgen, A. Aßmann, Sabine Möhner, & Thai Do Minh. (2010). Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study. Journal of Family Planning and Reproductive Health Care. 36(3). 123–129. 57 indexed citations
3.
Bardenheuer, Kristina, et al.. (2009). International Active Surveillance Study of Women Taking Oral Contraceptives (INAS-OC Study). BMC Medical Research Methodology. 9(1). 77–77. 18 indexed citations
4.
Schramm, Wolfgang, et al.. (2008). Die bayerische Thromboembolierisiko-Kohortenstudie (BATER): Studienprotokoll, Stand der Untersuchung und erste Ergebnisse. DMW - Deutsche Medizinische Wochenschrift. 125(01/02). 2–6. 1 indexed citations
5.
Dinger, Jürgen, Lothar Heinemann, Sabine Möhner, Do Minh Thai, & A. Aßmann. (2007). Colon cancer risk and different HRT formulations: a case-control study. BMC Cancer. 7(1). 76–76. 12 indexed citations
6.
Heinemann, Lothar, et al.. (2007). Analgesics use and ESRD in younger age: a case-control study. BMC Nephrology. 8(1). 15–15. 13 indexed citations
7.
Heinemann, Lothar, et al.. (2006). Breast cancer risk associated with different HRT formulations: a register-based case-control study. BMC Women s Health. 6(1). 13–13. 20 indexed citations
8.
Spannagl, Michael, Lothar Heinemann, Thai DoMinh, et al.. (2005). Comparison of incidence/risk of venous thromboembolism (VTE) among selected clinical and hereditary risk markers: A community-based cohort study. Thrombosis Journal. 3(1). 8–8. 14 indexed citations
9.
Heinemann, Lothar, Thai DoMinh, A. Aßmann, et al.. (2005). VTE Risk assessment – a prognostic Model: BATER Cohort Study of young women. Thrombosis Journal. 3(1). 5–5. 14 indexed citations
10.
Heinemann, Lothar, Michael A. O. Lewis, A. Aßmann, & Christine Thiel. (2002). Case-control studies on venous thromboembolism: bias due to design? A methodological study on venous thromboembolism and steroid hormone use. Contraception. 65(3). 207–214. 29 indexed citations
11.
Heinemann, Klaas, Sabine Moehner, Michael A. O. Lewis, et al.. (2002). Trend der OC-Nutzung in einer Deutschen Frauen-Kohorte 1980-1999 - Ergebnisse der Deutschen Kohortenstudie zur Frauengesundheit -. Zentralblatt für Gynäkologie. 124(2). 128–131. 7 indexed citations
12.
Heinemann, L, Christine Thiel, A. Aßmann, & Sabine Möhner. (2001). Gründe und Häufigkeit von Wechsel/Stopp der Einnahme oraler Kontrazeptiva. Ergebnisse der Deutschen Kohortenstudie zur Frauengesundheit. Zentralblatt für Gynäkologie. 123(10). 568–577. 3 indexed citations
13.
Thiel, Christine, Lothar Heinemann, & A. Aßmann. (2001). Gründe für eine Veränderung der HRT-Therapie aus der Sicht der Frauen - Ergebnisse der Deutschen Kohortenstudie zur Frauengesundheit -. Zentralblatt für Gynäkologie. 123(7). 390–398. 5 indexed citations
14.
15.
Heinemann, Lothar, A. Aßmann, Thai DoMinh, & Edeltraut Garbe. (1999). Oral progestogen-only contraceptives and cardiovascular risk: Results from the Transnational Study on Oral Contraceptives and the Health of Young Women. The European Journal of Contraception & Reproductive Health Care. 4(2). 67–73. 83 indexed citations
16.
Heinemann, Lothar, A. Aßmann, M. Spannagl, et al.. (1998). Normalized activated protein C ratio itself not associated with increased risk of venous thromboembolism. Contraception. 58(5). 321–322. 12 indexed citations
17.
Spannagl, Michael, Andrea Dick, A. Aßmann, Lothar Heinemann, & Wolfgang Schramm. (1998). Resistance to Activated Protein C in Women Using Oral Contraceptives. Seminars in Thrombosis and Hemostasis. 24(5). 423–430. 12 indexed citations
18.
19.
20.
Heinemann, Lothar, Hans G. Heine, A. Aßmann, et al.. (1988). Risk factors in the population of the GDR‐MONICA Study (1983/84). Acta Medica Scandinavica. 224(S728). 144–149. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.‐C. Todd Breakdown of academic impact, for papers by Annica Bergendal Breakdown of academic impact, for papers by Kresten Rubeck Petersen Breakdown of academic impact, for papers by Frederick Pellegrin Breakdown of academic impact, for papers by Sabine Möhner Breakdown of academic impact, for papers by G Rybo Breakdown of academic impact, for papers by Reinhard Meister Breakdown of academic impact, for papers by J Tzafettas Breakdown of academic impact, for papers by Torun Clausen Breakdown of academic impact, for papers by Osman Şevket
Rankless by CCL
2026